← Back to Search
Intranasal Immunization With C. Muridarum Major Outer Membrane Protein (MOMP) And Cholera Toxin Elicits Local Production Of Neutralising IgA In The Prostate.
D. Hickey, Russell C. Jones, S. Bao, A. E. Blake, K. Skelding, L. J. Berry, K. Beagley
Published 2004 · Biology, Medicine
Save to my Library
Download via 🐼 PaperPanda Download via oaDOI Download via OAB Download via LibKey Download via Google Google ScholarAnalyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Successful control of sexually transmitted diseases (STDs) through vaccination will require the development of vaccine strategies that target protective immunity to both the female and male reproductive tracts (MRT). In the male, the immune privileged nature of the male reproductive tract provides a barrier to entry of serum immunoglobulins into the male reproductive ducts, thereby preventing the induction of protective immunity using conventional injectable vaccination techniques. In this study we investigated the potential of intranasal (IN) immunization to elicit anti-chlamydial immunity in BALB/c male mice. Intranasal immunization with Chlamydia muridarum major outer membrane protein (MOMP) admixed with cholera toxin (CT) resulted in high levels of MOMP-specific IgA in prostatic fluids (PF) and MOMP-specific IgA-secreting cells in the prostate. Prostatic fluid IgA inhibited in vitro infection of McCoy cells with C. muridarum. Using RT-PCR we also show that mRNA for the polymeric immunoglobulin receptor (PIgR), which transports IgA across mucosal epithelia, is expressed only in the prostate but not in other regions of the male reproductive ducts upstream of the prostate. These data suggest that using intranasal immunization to target IgA to the prostate may protect males against STDs while at the same time maintaining the state of immune privilege within the MRT.
This paper references
Protein and immunoglobulin content of rete testis fluid of rams.
M. H. Johnson (1968)
Immunologic sequelae of experimental thermal injury to the testis.
F. Rapaport (1969)
The blood-testis barrier in the rat and the physiological compartmentation of the seminiferous epithelium.
M. Dym (1970)
The distribution of immunoglobulin and spermatozoal autoantigen in the genital tract of the male guinea pig: its relationship to autoallergic orchitis.
M. Johnson (1972)
Regional differentiation of cell junctions in the excurrent duct epithelium of the rat testis as revealed by freeze‐fracture
F. Suzuki (1978)
Immunoglobulin Classes, Secretory Component, and Sperm Agglutinins in Semen After Vasovasostomy *
L. Linnet (1982)
Antisperm Antibodies and Infertility
Serge Rousseau (1983)
Restricted entry of an anti-rat epididymal protein IgG into the rat epididymis.
P. Wong (1983)
Immunoglobulin‐producing cells in human prostate
M. Béné (1988)
The developmental biology of T lymphocytes.
H. Boehmer (1988)
Male genital mycoplasmas and Chlamydia trachomatis culture: its relationship with accessory gland function, sperm quality, and autoimmunity.
Y. Soffer (1990)
The Complement System in Human Reproduction
O. Vanderpuye (1992)
Urethral glands of the male mouse contain secretory component and immunoglobulin A plasma cells and are targets of testosterone.
M. Parr (1992)
C. Goodnow (1992)
Intracellular neutralization of virus by immunoglobulin A antibodies.
M. Mazanec (1992)
Secretory immune system of the male reproductive tract: effects of dihydrotestosterone and estradiol on IgA and secretory component levels.
J. Stern (1992)
A three-tiered view of the role of IgA in mucosal defense.
M. Mazanec (1993)
Characterization of T lymphocytes and antigen-presenting cells in the murine male urethra.
A. Quayle (1994)
Micropuncture and cannulation studies of fluid composition and transport in the ductuli efferentes testis of the rat: comparisons with the homologous metanephric proximal tubule
J. Clulow (1994)
Immunologic infertility : Male infertility
P. Turek (1994)
Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection
T. W. Cotter (1995)
Human male genitourinary tract: an immunohistochemical study of secretory IgA.
P. Sirigu (1995)
Regulation of the transport of immunoglobulin G into the male rat reproductive tract.
P. Pöllänen (1995)
Structure and turnover of junctional complexes between principal cells of the rat epididymis
D. Cyr (1995)
Immunohistochemical study of secretory IGA in the human male reproductive tract
P. Sirigu (1995)
Immunobiology of the human penile urethra.
J. Pudney (1995)
Cloning and characterization of a Chlamydia psittaci gene coding for a protein localized in the inclusion membrane of infected cells
D. Rockey (1995)
Protective Effect of Rotavirus VP6-Specific IgA Monoclonal Antibodies That Lack Neutralizing Activity
John W. Burns (1996)
A recombinant Chlamydia trachomatis major outer membrane protein binds to heparan sulfate receptors on epithelial cells.
H. Su (1996)
In vivo microperfusion of the ductuli efferentes testis of the rat: flow dependence of fluid reabsorption
J. Clulow (1996)
The Hidden Epidemic: Confronting Sexually Transmitted Diseases
T. Eng (1997)
Monoclonal immunoglobulin A antibody to the major outer membrane protein of the Chlamydia trachomatis mouse pneumonitis biovar protects mice against a chlamydial genital challenge.
S. Pal (1997)
Seminal plasma immunoglobulin concentrations in autoimmune male subfertility.
M. Luckas (1998)
Sexually transmitted diseases and reproductive health in women.
H. V. Burst (1998)
Immune responses in the epididymis: implications for immunocontraception.
K. Beagley (1998)
Immunoglobulin Entry into the Male Reproductive Tract: Implications for immunocontraception and vaccine development
K. Beagley (1999)
Cutting edge: coordinate regulation of IFN regulatory factor-1 and the polymeric Ig receptor by proinflammatory cytokines.
V. J. Blanch (1999)
Transcutaneous immunization induces mucosal and systemic immunity: a potent method for targeting immunity to the female reproductive tract.
C. Gockel (2000)
Chlamydia trachomatis infection: incidence, health costs and prospects for vaccine development.
K. Beagley (2000)
A secondary structure motif predictive of protein localization to the chlamydial inclusion membrane
CD8+ T cells recognize an inclusion membrane-associated protein from the vacuolar pathogen Chlamydia trachomatis.
S. Fling (2001)
Prostatitis: what is the role of infection.
J. Krieger (2002)
Chronic prostatitis: epidemiology and role of infection.
J. Krieger (2002)
The role of Chlamydia trachomatis in prostatitis.
W. Weidner (2002)
Restricted Entry of IgG into Male and Female Rabbit Reproductive Ducts Following Immunization with Recombinant Rabbit PH‐20
M. Pomering (2002)
Immunity to Murine Chlamydial Genital Infection
R. Morrison (2002)
Vaccines for Chlamydia trachomatis infections.
L. M. de la Maza (2002)
Aetiology of chronic prostatitis.
V. Škerk (2002)
Proteins in the chlamydial inclusion membrane.
D. Rockey (2002)
Deficiency of the mouse complement regulatory protein mCd59b results in spontaneous hemolytic anemia with platelet activation and progressive male infertility.
Xuebin Qin (2003)
Intraepithelial and stromal lymphocytes in the normal human prostate
D. Bostwick (2003)
Prostate biopsy culture findings of men with chronic pelvic pain syndrome do not differ from those of healthy controls.
Jay C. Lee (2003)
The composition of fluid collected by micropuncture and catheterization from the seminiferous tubules and rete testis of rats
R. Tuck (2004)
Chapter 96 – Human Male Genital Tract Immunity and Experimental Models
D. Anderson (2005)
This paper is referenced by
Hair follicle immune privilege and its collapse in alopecia areata
M. Bertolini (2020)
Mucosal immunization with polymeric antigen BLSOmp31 using alternative delivery systems against Brucella ovis in rams.
A. Díaz (2019)
Seventy Years of Chlamydia Vaccine Research – Limitations of the Past and Directions for the Future
Samuel L Phillips (2019)
The origin of prostate gland-secreted IgA and IgG
J. A. F. Silva (2017)
Short Communication : CD 4 + T cells reduce the tissue burden of Chlamydia muridarum in male BALB / c mice
K. Cunningham (2017)
Protection against genital tract Chlamydia trachomatis infection following intranasal immunization with a novel recombinant MOMP VS2/4 antigen
R. Hadad (2016)
Development of a chlamydial vaccine for koalas (Phascolarctos cinereus)
S. A. Khan (2016)
CTA 1-DD is an effective adjuvant for targeting anti-chlamydial immunity to the genital mucosa
K. Cunningham (2014)
The OmpA family of proteins: roles in bacterial pathogenesis and immunity.
A. Confer (2013)
Alternative vaccine delivery methods
B. Weniger (2013)
The development of an effective vaccine against Chlamydia : utilisation of a non-toxic mucosal adjuvant to generate a protective mucosal response
C. O'Meara (2012)
A Peptide Containing T-Cell Epitopes of Chlamydia trachomatis Recombinant MOMP Induces Systemic and Mucosal Antibody Responses in Mice
M. Taha (2011)
Organ system Target Male Female Hypothalamic – pituitary axis Gonadotrophs Gonadotrophs Gonads Germ cell Ovarian follicle Sertoli cell Oocyte Leydig cell Granulosa cell
R. J. Aitkena (2011)
Is there a role for immunocontraception?
E. McLaughlin (2011)
Chlamydia muridarum Major Outer Membrane Protein‐Specific Antibodies Inhibit In Vitro Infection but Enhance Pathology In Vivo
Kelly A. Cunningham (2011)
CD 4 + T cells reduce the tissue burden of Chlamydia muridarum in male BALB / c mice
K. Cunningham (2011)
CD4+ T cells reduce the tissue burden of Chlamydia muridarum in male BALB/c mice.
K. Cunningham (2010)
CD4+ T Cells and Antibody Are Required for Optimal Major Outer Membrane Protein Vaccine-Induced Immunity to Chlamydia muridarum Genital Infection
Christina M Farris (2010)
Towards a Chlamydia trachomatis vaccine: how close are we?
M. Cochrane (2010)
Vaccination against Chlamydia Genital Infection Utilizing the Murine C. muridarum Model
Christina M. Farris (2010)
Transcutaneous immunization with a novel lipid-based adjuvant protects against Chlamydia genital and respiratory infections.
D. Hickey (2009)
Expression of Immunoglobulin Gene With Classical V-(D)-J Rearrangement in Mouse Testis and Epididymis
Jing Huang (2009)
Transcutaneous immunization with novel lipid-based adjuvants induces protection against gastric Helicobacter pylori infection.
Danica K. Hickey (2009)
CTA1-DD is an effective adjuvant for targeting anti-chlamydial immunity to the murine genital mucosa.
Kelly A. Cunningham (2009)
Genital tract CD4 + T cells for vaccination and protection against Chlamydia trachomatis
Ellen Marks (2009)
ORIGINAL ARTICLE: Poly‐Immunoglobulin Receptor‐Mediated Transport of IgA into the Male Genital Tract is Important for Clearance of Chlamydia muridarum Infection
Kelly A. Cunningham (2008)
Immune privilege or privileged immunity?
J. Forrester (2008)
Male Genital Tract Chlamydial Infection: Implications for Pathology and Infertility1
Kelly A. Cunningham (2008)
Alternative vaccine delivery methods
B. Weniger (2008)
Chlamydia trachomatis infection: host immune responses and potential vaccines
L. Hafner (2008)
Immunity Against Chlamydia trachomatis
E. Marks (2008)
CCL5 regulation of mucosal chlamydial immunity and infection
Senthilkumar K. Sakthivel (2008)See more